skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
07/14/2015
Application #:
14483837
Filing Dt:
09/11/2014
Publication #:
Pub Dt:
03/19/2015
Inventors:
Ulhas DHUPPAD, Ashok Katkurwar, Yashwant Gupta, Rajesh Ankam, Chandrakant Dhatrak
Title:
STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE
Assignment: 1
Reel/Frame:
033723/0857Recorded: 09/11/2014Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
09/09/2014
Exec Dt:
09/09/2014
Exec Dt:
09/09/2014
Exec Dt:
09/09/2014
Exec Dt:
09/09/2014
Assignee:
GLENMARK HOUSE HDO - CORPORATE BLDG, WING - A, B. D.
SAWANT MARG, CHAKALA, ANDHERI (EAST)
MUMBAI, INDIA 400099
Correspondent:
GLENMARK PHARMACEUTICALS S.A. C/O BLANK
ATTN: PATENT DOCKETING
600 NEW HAMPSHIRE AVENUE NW
WASHINGTON, DC 20037
Assignment: 2
Reel/Frame:
037947/0625Recorded: 03/10/2016Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/15/2015
Assignee:
AVENUE LEOPOLD-ROBERT 37
LA CHAUX-DE-FONDS, SWITZERLAND 2300
Correspondent:
BLANK ROME LLP
THE CHRYSLER BUILDING
405 LEXINGTON AVENUE
NEW YORK, NY 10174
Assignment: 3
Reel/Frame:
065379/0694Recorded: 10/26/2023Pages: 7
Conveyance:
CHANGE OF ADDRESS
Assignor:
Exec Dt:
10/26/2023
Assignee:
PLACE DU PORT 2
NEUCHÂTEL, SWITZERLAND 2000
Correspondent:
BLANK ROME LLP
1271 AVENUE OF THE AMERICAS, 15TH FLOOR
NEW YORK, NY 10020

Search Results as of: 05/29/2024 02:11 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT